Cutaneous Mucormycosis by Saksenaea vasiformis: An Unusual Case Report and Review of Literature
- 65 Downloads
Saksenaea vasiformis is one of the numerous fungi of the Order Mucorales. Rapid progression and invasion of neighboring tissues are the most characteristic features of S. vasiformis mucormycosis.
The objective of this review is the management of this type of infections.
Case report and literature review.
A 62-year old woman, without a history of immunocompromisation, developed a localized cutaneous infection at her right thigh. No trauma, skin laceration or insect bite was reported at the side of infection. The initial treatment was surgical debridements and intravenous administration of amphotericin B/posaconazole. In order to avoid the further rapid progression of the infection and save her life, it was decided to proceed to amputation of the patient’s right leg. This is the first case of S. vasiformis cutaneous infection in an immunocompetent patient, in Greece.
Early diagnosis of S. vasiformis mucormycosis is of paramount importance. Clinical suspicion, based on the rapid progression of the infection and on the medical history of the patient, is sufficient to start antifungal treatment. Broad, aggressive, and repeated surgical debridement of the infection site together with systemic antifungal agents administration is the key point for successful treatment.
KeywordsCutaneous zygomycosis Saksenaea vasiformis Zygomycosis Amphotericin B Posaconazole Mucormycosis
The authors would like to thank Dr M. Lelekis and Prof. A. Velegraki for their significant clinical support and advice.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed consent was obtained from the patient included in the study.
- 6.Wilson PA. Zygomycosis due to Saksenaea vasiformis caused by a magpie peck. Med J Aust. 2008;189:521–2.Google Scholar
- 8.Rodriguez-Tudela JL, Donnelly JP, Arendrup MC, et al. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds—subcommittee on antifungal susceptibility testing (AFST) of the ESCMID European committee for antimicrobial susceptibility testing (EUCAST). Clin Microbiol Infect. 2008;14:982–4.CrossRefGoogle Scholar
- 26.Trotter DJ, Gonis G, Cottrill E, et al. Disseminated Saksenaea vasiformis in an immunocompetent host. Med J Aust. 2008;189:519–20.Google Scholar
- 42.Pritchard RC, Muir DB, Archer KH, et al. Subcutaneous zygomycosis due to Saksenaea vasiformis in an infant. Med J Aust. 1986;145:630–1.Google Scholar
- 44.Holland J. Emerging zygomycoses of humans: Saksenaea vasiformis and Apophysomyces elegans. Curr Top Med Mycol. 1997;8:27–34.Google Scholar
- 48.Pilch WT, Kinnear N, Hennessey DB (2017) Saksenaea vasiformis infection in an immunocompetent patient in rural Australia. BMJ Case Rep;2017. pii: bcr-2017-220341.Google Scholar
- 54.Campelo C, de Miguel S, del Palacio A. Zigomicosis rinocerebral causada por Saksenaea vasiformis en un paciente diabetico. Enferm Infecc Microbiol Clin. 2005;23(Suppl 1):77.Google Scholar
- 56.Tendolkar U, Baradkar V, Baveja S, et al. Cutaneous zygomycosis due to Saksenaea vasiformis in a patient with paraparesis, burns and pressure ulcer. Internet J Infect Dis. 2012;10:1–4.Google Scholar